Treatment of progressive multifocal leukoencephalopathy with interleukin 7

JAMA Neurology

Volumn 71, Issue 8, 2014, Pages 1030-1035

  Alstadhaug, Karl B ^a,b   Croughs, Theŕèse ^c   Henriksen, Stian ^d   Leboeuf, Ceĺine ^e   Sereti, Irini ^f   Hirsch, Hans H ^e,g   Rinaldo, Christine Hanssen ^b,d  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c Cytheris SA   (France)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^e UNIVERSITY OF BASEL   (Switzerland)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; ETIRACETAM; HARKOSERIDE; IMMUNOGLOBULIN M; INTERLEUKIN 7; MIRTAZAPINE; RECOMBINANT INTERLEUKIN 7; VALPROIC ACID; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD LEVEL; BRAIN BIOPSY; BRAIN LEVEL; CASE REPORT; CD4 LYMPHOCYTE COUNT; CELL LEVEL; CLINICAL FEATURE; DISEASE ASSOCIATION; DNA SEQUENCE; DRUG RESPONSE; DRUG WITHDRAWAL; EPILEPTIC STATE; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; JC VIRUS; LYMPHOCYTOPENIA; MALE; MEDICAL HISTORY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SEQUENCE ANALYSIS; TONIC CLONIC SEIZURE; VIRUS GENE; VIRUS GENOME; VIRUS STRAIN; VP1 GENE; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; T-LYMPHOCYTOPENIA, IDIOPATHIC CD4-POSITIVE; VIROLOGY;

HUMANS; INTERLEUKIN-7; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; T-LYMPHOCYTOPENIA, IDIOPATHIC CD4-POSITIVE;

EID: 84905965223     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.825     Document Type: Article

References (15)

1. Ferenczy MW, Marshall LJ, Nelson CD, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25(3):471-506.
2. Delgado-Alvarado M, Sedano MJ, González-Quintanilla V, de Lucas EM, Polo JM, Berciano J. Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia. J Neurol Sci. 2013;327(1-2):75-79.
3. Zonios DI, Falloon J, Bennett JE, et al. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood. 2008;112(2):287-294.
4. Gasnault J, Costagliola D, Hendel-Chavez H, et al ANRS 125 Trial Team. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. PLoS One. 2011;6(6):e20967.
5. Dumoulin A, Hirsch HH. Reevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphisms. J Clin Microbiol. 2011;49(4):1382-1388.
6. Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306(5700):1380-1383. (Pubitemid 39532516)
7. Gheuens S, Wüthrich C, Koralnik IJ. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol. 2013;8:189-215.
8. Gorelik L, Reid C, Testa M, et al. Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. J Infect Dis. 2011;204(1):103-114.
9. Cubitt CL, Cui X, Agostini HT, et al. Predicted amino acid sequences for 100 JCV strains. J Neurovirol. 2001;7(4):339-344. (Pubitemid 32894238)
10. Kuhle J, Gosert R, Bühler R, et al. Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology. 2011;77(23):2010-2016.
11. Moore DM, Harris R, Lima V, et al Antiretroviral Therapy Cohort Collaboration. Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression. J Acquir Immune Defic Syndr. 2009;52(3):357-363.
12. Marzocchetti A, Tompkins T, Clifford DB, et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009;73(19):1551-1558.
13. Aly L, Yousef S, Schippling S, et al. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain. 2011;134(pt 9):2687-2702.
14. Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 2011;11(5):330-342.
15. Khanna N, Wolbers M, Mueller NJ, et al Swiss HIV Cohort Study. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol. 2009;83(9):4404-4411.